波尔的摩市对制造商/分销商的11亿美元阿片类药物诉讼可以继续进行审判. Baltimore's $11bn opioid lawsuit against manufacturers/distributors can proceed to trial.

巴尔的摩针对制造商/分销商的110亿美元阿片类药物诉讼可以进行审判，因为市法官拒绝了公司的驳回动议。 Baltimore's $11bn opioid lawsuit against manufacturers/distributors can proceed to trial as city judge denies companies' motions to dismiss. 巴尔的摩声称，公司向该市注入了数百万种合法的阿片类药物处方，淡化了成瘾性并积极进行营销。 Baltimore alleges companies flooded city with millions of legal opioid prescriptions, downplaying addictiveness and aggressively marketing. 审判定于 9 月 16 日进行，巴尔的摩寻求赔偿，以资助涉及药物治疗、过量预防和其他服务的阿片类药物减少计划。 Trial set for 16 Sept. Baltimore seeks damages to fund opioid abatement plan involving drug treatment, overdose prevention, and other services.